Flavopiridol-Hydrochloride-HL-275-DataSheet-MedChemExpress_第1頁(yè)
Flavopiridol-Hydrochloride-HL-275-DataSheet-MedChemExpress_第2頁(yè)
Flavopiridol-Hydrochloride-HL-275-DataSheet-MedChemExpress_第3頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEFlavopiridol HydrochlorideCat. No.: HY-10006CAS No.: 131740-09-5Synonyms: HL 275; NSC 649890; MDL 107826A; FLAVOPIRIDOL HCL;Alvocidib Hydrochloride分式: CHClNO分量: 438.3作靶點(diǎn): CDK; Autophagy作通路: Cell Cycle/DNA Damage; Autophagy儲(chǔ)存式: P

2、owder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) H2O : 20 mg/mL (45.63 mM)* means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制備儲(chǔ)備液1 mM 2.2815 mL 11.4077 mL 22.8154 mL5 mM 0.4563 mL 2.2815 mL 4.5631 mL10 mM 0.2282 mL 1.1408 mL 2.2815 mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑

3、中的溶解度,選擇合適的溶劑配制儲(chǔ)備液,并請(qǐng)注意儲(chǔ)備液的保存式和期限。BIOLOGICAL ACTIVITY物活性 Flavopiridol Hydrochloride種 CDK 的譜抑制劑,與 ATP 競(jìng)爭(zhēng)性地抑制 CDK1,CDK2 和 CDK4 的活性,IC50 值分別為 30, 170, 100 nM。IC50 & Target CDK1/Cyc B1 CDK2/Cyc E CDK4/Cyc D1 MAP1/3 Master of Small Molecules 您邊的抑制劑師www.MedChemE30 nM (IC50) 170 nM (IC50) 100 nM (IC50) 190

4、00 nM (IC50)PKC EGFR14000 nM (IC50) 22000 nM (IC50)體外研究 Flavopiridol (2 M) robustly induces a distinct pattern of ER stress in CLL cells that contributes to cell deaththrough IRE1-mediated activation of ASK1 and possibly downstream caspases 1. Flavopiridol results inpotent upregulation of a number o

5、f PRGs in treatments lasting 4-24 h. Flavopiridol has and immediate andlong-term effect on the expression of several PRGs. In serum starved cells re-stimulated with serum,flavopiridol also inhibits the expression of these genes, but subsequently, JUNB, GADD45B and EGR1 areupregulated in the presence

6、 of flavopiridol 2.PROTOCOLKinase Assay 1 Briefly, lysates containing approximately 3106 cells are incubated with 50 M LEVD-AFC (caspase 4substrate) or LETD-AFC (caspase 8 substrate) containing 10 mM dithiothretiol (DTT). Caspase 4 activity ismeasured one hour after addition of substrate and caspase

7、 8 activity is measured 30 minutes after additionof substrate. Release of free AFC is measured with a Beckman-Coulter DTX 880 multimode detector.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Cell Assay 1 The cells treated with flavopiridol are washed

8、after 4 hours with PBS and resuspended in regular growthmedium (RPMI 1640) supplemented with 10% human serum and antibiotics for the remainder of theincubation time. In the case of flavopiridol/chloroquine samples, chloroquine is re-added in the fresh mediaafter flavopiridol is washed at 4 hours. Fo

9、r all the other conditions, cells are incubated with the respectivedrugs for 24 hours continuously.MCE has not independently confirmed the accuracy of these methods. They are for reference only.戶使本產(chǎn)品發(fā)表的科研獻(xiàn) Sci Transl Med. 2018 Jul 18;10(450). pii: eaaq1093. Biomaterials. 2014 Aug;35(24):6585-94. Bio

10、materials. 2014 Aug;35(24):6585-94. Cell Syst. 2018 Apr 25;6(4):424-443.e7. Cell Chem Biol. 2019 Jun 6. pii: S2451-9456(19)30174-6.See more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Mahoney E, et al. ER stress and autophagy: new discoveries in the mechanism of action and drug resi

11、stance of the cyclin-dependentkinase inhibitor flavopiridol.Blood. 2012 Aug 9;120(6):1262-1273.2. Keskin H, et al. Complex effects of flavopiridol on the expression of primary response genes. Cell Div. 2012 Mar 29;7:11.3. Kim KS, et al.Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: synthesis and biological effects. J Med Chem.2/3 Master of Small Molecules 您邊的抑制劑師www.MedChemE2000 Nov 2;43(22):4126-34.McePdfHeightCaution: Product h

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論